Skip to main content
Equibles
NSPR logo

NSPR · InspireMD, Inc.

Track NSPR — free

Use NSPR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.85 +0.01 (+1.26%) At close · Sep 4
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has concluded that there is substantial doubt about our ability to continue as a going concern, and our condensed financial statements for the quarter ended June 30, 2026 includes an explanatory paragraph as to our ability to continue as a going concern, which could prevent us from obtaining new financing on reasonable terms or at all.”
View the 10-Q filed Aug 14, 2026
Market Cap
$39.66M
Shares
46.49M

NSPR metrics

64 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.85
Market cap
$39.66M

Price action

19 metrics
Price change (1W)
+0.4%
Price change (30D)
+6.6%
Price change (3M)
-3.0%
Price change (6M)
-48.0%
Price change (YTD)
-52.1%
Price change (1Y)
-65.0%
Trailing year
Price change (5Y)
-81.0%
52-week high
$2.50
52-week low
$0.65
Change from 52-week high
-65.9%
Change from 52-week low
+31.3%
Annualized volatility
61.6%
Beta
1.0
RSI (14D)
51.8
Price vs SMA 50
+10.6%
Price vs SMA 200
-35.5%
Avg volume (3M)
96,343
Relative volume
0.3
Average dollar volume
$76,003

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
46.49M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.7×
reciprocal yield 27.3%
P / book
1.3
reciprocal yield 79.4%
FCF yield
-107.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-132.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-17

Profitability

9 metrics
Gross margin
18.1%
Operating margin
-494.0%
Trailing 12 months
Net margin
-484.1%
Gross profit (TTM)
$1.96M
Operating profit (TTM)
−$53.56M
Net income (TTM)
−$52.48M
Trailing 12 months
Diluted EPS (TTM)
$-1.05
FCF margin
-391.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.11

Growth

11 metrics
Revenue growth YoY
-0.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$10.84M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+66.0%
Year over year · more shares
Revenue CAGR (3Y)
+20.2%
Revenue CAGR (5Y)
+29.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-166.6%
Return on assets
-117.6%
Debt / equity
—
Current ratio
3.8
EBITDA (TTM)
−$9.66M
Free cash flow (TTM)
−$42.46M
Quick ratio
3.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$15.15M
Total assets
$44.64M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$41.21M
Capital expenditures (TTM)
$1.25M
R&D (TTM)
$16.17M
SG&A (TTM)
—
Stock compensation (TTM)
$10.71M
R&D / revenue
149.1%
Stock compensation / revenue
98.8%

Ownership (13F)

3 metrics
13F filers
38
13F filer change QoQ
+3
Institutional ownership
46.3%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1433607 CUSIP 45779A846 13F (30d) 24 filings 24 filers Visit website Investor relations